JPMorgan Chase & Co’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-500
| Closed | -$1K | – | 4873 |
|
|
2017
Q3 | $1K | Hold |
500
| – | – | ﹤0.01% | 4273 |
|
|
2017
Q2 | $1K | Hold |
500
| – | – | ﹤0.01% | 4305 |
|
|
2017
Q1 | $2K | Hold |
500
| – | – | ﹤0.01% | 4374 |
|
|
2016
Q4 | $1K | Sell |
500
-100
| -17% | -$200 | ﹤0.01% | 4438 |
|
|
2016
Q3 | $2K | Buy |
600
+500
| +500% | +$1.67K | ﹤0.01% | 4013 |
|
|
2016
Q2 | $0 | Sell |
100
-55,173
| -100% | – | ﹤0.01% | 4583 |
|
|
2016
Q1 | $311K | Buy |
55,273
+2,573
| +5% | +$14.5K | ﹤0.01% | 3044 |
|
|
2015
Q4 | $907K | Buy |
52,700
+29,744
| +130% | +$512K | ﹤0.01% | 2709 |
|
|
2015
Q3 | $484K | Sell |
22,956
-20,098
| -47% | -$424K | ﹤0.01% | 2947 |
|
|
2015
Q2 | $2.13M | Buy |
43,054
+14,286
| +50% | +$707K | ﹤0.01% | 2496 |
|
|
2015
Q1 | $2.25M | Sell |
28,768
-56,675
| -66% | -$4.44M | ﹤0.01% | 2481 |
|
|
2014
Q4 | $5.18M | Buy |
85,443
+82,137
| +2,484% | +$4.98M | ﹤0.01% | 2036 |
|
|
2014
Q3 | $141K | Hold |
3,306
| – | – | ﹤0.01% | 3311 |
|
|
2014
Q2 | $204K | Sell |
3,306
-30,784
| -90% | -$1.9M | ﹤0.01% | 3298 |
|
|
2014
Q1 | $2.22M | Buy |
34,090
+4,896
| +17% | +$318K | ﹤0.01% | 2453 |
|
|
2013
Q4 | $1.64M | Sell |
29,194
-7,833
| -21% | -$441K | ﹤0.01% | 2657 |
|
|
2013
Q3 | $2.27M | Sell |
37,027
-28,318
| -43% | -$1.74M | ﹤0.01% | 2511 |
|
|
2013
Q2 | $3.82M | Buy |
+65,345
| New | +$3.82M | ﹤0.01% | 2126 |
|